Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.

ABSTRACT:

SUBMITTER: Lee CH 

PROVIDER: S-EPMC12057554 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature